Annual Accounts Payable
$201.40 M
-$500.00 K-0.25%
31 December 2023
Summary:
Edwards Lifesciences annual accounts payable is currently $201.40 million, with the most recent change of -$500.00 thousand (-0.25%) on 31 December 2023. During the last 3 years, it has risen by +$4.90 million (+2.49%). EW annual accounts payable is now -1.52% below its all-time high of $204.50 million, reached on 31 December 2021.EW Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$172.80 M
-$13.10 M-7.05%
30 September 2024
Summary:
Edwards Lifesciences quarterly accounts payable is currently $172.80 million, with the most recent change of -$13.10 million (-7.05%) on 30 September 2024. Over the past year, it has dropped by -$17.80 million (-9.34%). EW quarterly accounts payable is now -28.48% below its all-time high of $241.60 million, reached on 31 March 2008.EW Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.3% | -9.3% |
| 3 y3 years | +2.5% | +23.9% |
| 5 y5 years | +50.3% | +27.1% |
EW Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.5% | +2.5% | -18.6% | +23.9% |
| 5 y | 5 years | -1.5% | +50.3% | -18.6% | +27.1% |
| alltime | all time | -1.5% | +323.1% | -28.5% | +263.0% |
Edwards Lifesciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $172.80 M(-7.0%) |
| June 2024 | - | $185.90 M(-12.4%) |
| Mar 2024 | - | $212.30 M(+5.4%) |
| Dec 2023 | $201.40 M(-0.2%) | $201.40 M(+5.7%) |
| Sept 2023 | - | $190.60 M(-1.2%) |
| June 2023 | - | $193.00 M(+6.7%) |
| Mar 2023 | - | $180.80 M(-10.5%) |
| Dec 2022 | $201.90 M(-1.3%) | $201.90 M(+30.3%) |
| Sept 2022 | - | $154.90 M(-4.7%) |
| June 2022 | - | $162.50 M(+2.3%) |
| Mar 2022 | - | $158.80 M(-22.3%) |
| Dec 2021 | $204.50 M(+4.1%) | $204.50 M(+46.6%) |
| Sept 2021 | - | $139.50 M(-3.5%) |
| June 2021 | - | $144.60 M(-3.9%) |
| Mar 2021 | - | $150.40 M(-23.5%) |
| Dec 2020 | $196.50 M(+8.9%) | $196.50 M(+20.9%) |
| Sept 2020 | - | $162.50 M(+5.9%) |
| June 2020 | - | $153.40 M(+1.3%) |
| Mar 2020 | - | $151.50 M(-16.0%) |
| Dec 2019 | $180.40 M(+34.6%) | $180.40 M(+32.7%) |
| Sept 2019 | - | $135.90 M(-10.0%) |
| June 2019 | - | $151.00 M(+2.6%) |
| Mar 2019 | - | $147.20 M(+9.9%) |
| Dec 2018 | $134.00 M(+14.9%) | $134.00 M(0.0%) |
| Sept 2018 | - | $134.00 M(+7.5%) |
| June 2018 | - | $124.60 M(+2.8%) |
| Mar 2018 | - | $121.20 M(+3.9%) |
| Dec 2017 | $116.60 M(+20.1%) | $116.60 M(+2.8%) |
| Sept 2017 | - | $113.40 M(+8.4%) |
| June 2017 | - | $104.60 M(+12.5%) |
| Mar 2017 | - | $93.00 M(-4.2%) |
| Dec 2016 | $97.10 M(+52.0%) | $97.10 M(+11.6%) |
| Sept 2016 | - | $87.00 M(+4.3%) |
| June 2016 | - | $83.40 M(+6.1%) |
| Mar 2016 | - | $78.60 M(+23.0%) |
| Dec 2015 | $63.90 M(+9.8%) | $63.90 M(-10.6%) |
| Sept 2015 | - | $71.50 M(+8.0%) |
| June 2015 | - | $66.20 M(-3.5%) |
| Mar 2015 | - | $68.60 M(+17.9%) |
| Dec 2014 | $58.20 M(+20.2%) | $58.20 M(-2.8%) |
| Sept 2014 | - | $59.90 M(+23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $48.40 M(-35.2%) | $48.40 M(-35.2%) |
| Dec 2012 | $74.70 M(-12.1%) | $74.70 M(-12.1%) |
| Dec 2011 | $85.00 M(+78.6%) | $85.00 M(+78.6%) |
| Dec 2010 | $47.60 M(-6.8%) | $47.60 M(-6.8%) |
| Dec 2009 | $51.10 M(-22.1%) | $51.10 M(-22.1%) |
| Dec 2008 | $65.60 M(+2.7%) | $65.60 M(-71.5%) |
| Sept 2008 | - | $229.90 M(+1.5%) |
| June 2008 | - | $226.60 M(-6.2%) |
| Mar 2008 | - | $241.60 M(+278.1%) |
| Dec 2007 | $63.90 M(+11.7%) | $63.90 M(-67.9%) |
| Sept 2007 | - | $198.80 M(+14.5%) |
| June 2007 | - | $173.60 M(-3.2%) |
| Mar 2007 | - | $179.40 M(+213.6%) |
| Dec 2006 | $57.20 M(-70.5%) | $57.20 M(-74.9%) |
| Sept 2006 | - | $227.50 M(+0.4%) |
| June 2006 | - | $226.50 M(+15.0%) |
| Mar 2006 | - | $197.00 M(+1.4%) |
| Dec 2005 | $194.20 M(-0.6%) | $194.20 M(-5.1%) |
| Sept 2005 | - | $204.60 M(+7.5%) |
| June 2005 | - | $190.40 M(+7.9%) |
| Mar 2005 | - | $176.40 M(-9.7%) |
| Dec 2004 | $195.40 M(+16.9%) | $195.40 M(+14.7%) |
| Sept 2004 | - | $170.30 M(+9.2%) |
| June 2004 | - | $156.00 M(-0.3%) |
| Mar 2004 | - | $156.40 M(-6.5%) |
| Dec 2003 | $167.20 M(-5.7%) | $167.20 M(-2.8%) |
| Sept 2003 | - | $172.00 M(-7.6%) |
| June 2003 | - | $186.10 M(-1.8%) |
| Mar 2003 | - | $189.60 M(+6.9%) |
| Dec 2002 | $177.30 M(-3.4%) | $177.30 M(+1.3%) |
| Sept 2002 | - | $175.00 M(-5.7%) |
| June 2002 | - | $185.50 M(+11.5%) |
| Mar 2002 | - | $166.30 M(-9.4%) |
| Dec 2001 | $183.50 M(+3.7%) | $183.50 M(+16.7%) |
| Sept 2001 | - | $157.20 M(+4.9%) |
| June 2001 | - | $149.90 M(-10.5%) |
| Mar 2001 | - | $167.40 M(-5.4%) |
| Dec 2000 | $177.00 M | $177.00 M(+39.6%) |
| Sept 2000 | - | $126.80 M(+4.8%) |
| June 2000 | - | $121.00 M(-0.8%) |
| Mar 2000 | - | $122.00 M |
FAQ
- What is Edwards Lifesciences annual accounts payable?
- What is the all time high annual accounts payable for Edwards Lifesciences?
- What is Edwards Lifesciences annual accounts payable year-on-year change?
- What is Edwards Lifesciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly accounts payable year-on-year change?
What is Edwards Lifesciences annual accounts payable?
The current annual accounts payable of EW is $201.40 M
What is the all time high annual accounts payable for Edwards Lifesciences?
Edwards Lifesciences all-time high annual accounts payable is $204.50 M
What is Edwards Lifesciences annual accounts payable year-on-year change?
Over the past year, EW annual accounts payable has changed by -$500.00 K (-0.25%)
What is Edwards Lifesciences quarterly accounts payable?
The current quarterly accounts payable of EW is $172.80 M
What is the all time high quarterly accounts payable for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly accounts payable is $241.60 M
What is Edwards Lifesciences quarterly accounts payable year-on-year change?
Over the past year, EW quarterly accounts payable has changed by -$17.80 M (-9.34%)